StonvexLoading…
StonvexStonvexStonvexCore line items from DRCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $34.69M | $62.29M | $157.11M | $116.10M |
Operating Income | $-14.76M | $-13.23M | $-2.19M | $6.61M |
Net Income | $-18.95M | $-6.24M | $-2.19M | $549.00K |
EPS (Diluted) | $-75.79 | $-91.26 | $-0.73 | $0.09 |
Total Assets | $20.16M | $26.01M | $68.94M | $86.75M |
Total Liabilities | $27.18M | $45.74M | $74.35M | $82.89M |
Cash & Equivalents | $728.00K | $1.45M | $5.12M | $5.48M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 308.00K | 68.00K | 2.99M | 3.08M |